:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Sun, Zenan
Format:	Recurso digital
Language:
Published:	Zenodo 2026
Online Access:	https://doi.org/10.5281/zenodo.20290088
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

AD-CDO: A Lightweight Ontology for Representing Eligibility Criteria in Alzheimer's Disease Clinical Trials
by: Sun, Zenan, et al.
Published: (2025)

The Clinical Trials Landscape for Alzheimer's Disease
by: Guoping Shen, et al.
Published: (2025)

Associations Between Alzheimer’s Disease and Obesity: Clinical Trials of NA‐831 for AD and NA‐931 for Obesity
by: Lloyd Tran, et al.
Published: (2024)

Impact of Site Size on Data Quality in Early Alzheimer’s Disease Clinical Trials
by: Alan Kott, et al.
Published: (2024)

SiteRx AI‐Enabled Clinical Intelligence Platform Delivers Superior Amyloid PET Conversion in Early Alzheimer’s Disease (AD) Trial
by: Erin Beck, et al.
Published: (2024)

Neuroimaging in Atypical AD: Considerations for Clinical Trials
by: Jennifer L. Whitwell
Published: (2025)

AD-GPT: Large Language Models in Alzheimer's Disease
by: Liu, Ziyu, et al.
Published: (2025)

The Common Core Ontologies
by: Jensen, Mark, et al.
Published: (2024)

Clinical Trials Ontology Engineering with Large Language Models
by: Çakır, Berkan
Published: (2024)

Feasibility of Identifying Aerobic‐Fitness Responses to Aerobic Exercise in Alzheimer's Disease: The FIT‐AD SMART Trial
by: Fang Yu, et al.
Published: (2025)

Perfectly Fitting CDO Prices Across Tranches: A Theoretical Framework with Efficient Algorithms
by: Bu, Lan, et al.
Published: (2026)

MÉTODO SIMPLIFICADO PARA DETERMINAR LA CURVA DE DISOCIACIÓN DE OXÍGENO (CDO)
by: Edgar CRISTANCHO
Published: (2019)

Rapid Progressors in Alzheimer's Disease: Implications for Symptomatic Clinical Trial Design
by: Madison Shyer, et al.
Published: (2025)

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Clinical Trial
by: Davangere P. Devanand, et al.
Published: (2025)

Identifying Problematic Subjects Entering Clinical Trials in Early Alzheimer’s Disease
by: Alan Kott, et al.
Published: (2025)

Impacts of Informant Replacement in Industry‐Sponsored Alzheimer’s Disease Clinical Trials
by: Mikaela K Nishida, et al.
Published: (2024)

Optimizing Alzheimer’s Disease Clinical Trials with Predictive Models of Cognitive Decline
by: Bhargav Teja Nallapu, et al.
Published: (2025)

AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation
by: Carmela R Abraham, et al.
Published: (2024)

Evaluation of Biomarkers in Active Alzheimer's Disease Intervention Clinical Trials – The Biomarker Observatory
by: Amanda M. Leisgang Osse, et al.
Published: (2025)

Baseline Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Clinical Trial
by: Rema Raman, et al.
Published: (2024)

Transitioning from Clinical Trial to Clinical Practice for Long‐Term Lecanemab Treatment in Early Alzheimer’s Disease: Perspectives from an Alzheimer’s Disease Treatment Center
by: David Watson, et al.
Published: (2025)

Testing Industry Assumptions About Raters’ Clinical Experience and Performance During Alzheimer’s Disease Clinical Trials
by: Katrina Patrick, et al.
Published: (2025)

Clinical Evaluation of Blood‐Based Assays for Rapid Detection of Amyloid‐β Pathology in Alzheimer's Disease (CLEAR‐AD)
by: Xinyi Lyu, et al.
Published: (2025)

Subgroup Identification in Alzheimer's Disease Trial
by: Lei Liu
Published: (2025)

Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons
by: Robert L. Grossman, et al.
Published: (2025)

Blarcamesine in Early Alzheimer Disease Phase 2b/3 Randomized Clinical Trial
by: Marwan N. Sabbagh, et al.
Published: (2024)

Common indels from gnomAD
by: Dong, Guanlan
Published: (2025)

Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction
by: Hu, Xinyue, et al.
Published: (2023)

TrialSynth: Generation of Synthetic Sequential Clinical Trial Data
by: Gao, Chufan, et al.
Published: (2024)

AD-Reasoning: Multimodal Guideline-Guided Reasoning for Alzheimer's Disease Diagnosis
by: Chen, Qiuhui, et al.
Published: (2026)

CTG-DB: An Ontology-Based Transformation of ClinicalTrials.gov to Enable Cross-Trial Drug Safety Analyses
by: Painter, Jeffery L., et al.
Published: (2026)

Contribution of cardiovascular comorbidities to Alzheimer’s Disease (AD) among older adults with low plasma AD biomarker level
by: Yian Gu, et al.
Published: (2024)

Comparison of Relative Change with Effect Size Metrics in Alzheimer’s Disease Anti‐amyloid Clinical Trials
by: Terry E. Goldberg, et al.
Published: (2024)

Assessing the Performance of Confirmatory Cognitive Tests in Screening Subjects for Early Alzheimer's Disease Clinical Trials
by: David S. Miller, et al.
Published: (2025)

Alzheimer's Disease Clinical Trials: What Have We Learned From Magnetic Resonance Imaging
by: Samantha By, et al.
Published: (2024)

Trends in Clinical Trials: Investigating the Role of Inflammation in Alzheimer's Disease and Its Implications for Drug Development
by: Raj Kumar, et al.
Published: (2025)

OntoCaimer: Towards an Ontological Model to Support the Care of Patients with Alzheimer's Disease
by: Laura-Daniela Lasso-Arciniegas
Published: (2023)

Associations Between Alzheimer’s Disease and Rett Syndrome: Clinical Trials of NA‐831 for the Treatment Alzheimer’s and NA‐921 for Rett Syndrome
by: Lloyd Tran, et al.
Published: (2025)

A Data‐driven Approach for Genetic Prediction of Alzheimer's Diseases when Polygenic RiskScores Fail to account AD's Genetic Complexity
by: Aditya Purswani, et al.
Published: (2025)

Meta‐analysis of NIH Alzheimer’s Disease‐Related Dementias (ADRD) programs responsive to the National Plan to Address Alzheimer’s Disease (AD)
by: Amber J McCartney, et al.
Published: (2024)